NCT04794114

Brief Summary

hemiplegia is a pathological condition that affects one side of the body which is associated with difficulty in maintaining an upright posture and walking and which is commonly compensated for by using orthoses (AFO). However, the orthoses are inadequate for sports from a design and prescription point of view, which specifies that the goal of the orthosis is to support walking and that any other use compromises its reliability. The main objective therefore provides for an improvement in the involvement of these children in sports activities (both at school and during leisure time) through the development of new generation orthoses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 11, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2021

Completed
Last Updated

May 1, 2025

Status Verified

April 1, 2025

Enrollment Period

1.2 years

First QC Date

February 11, 2021

Last Update Submit

April 30, 2025

Conditions

Keywords

orthosishemiplegia

Outcome Measures

Primary Outcomes (2)

  • gait analysis with standard ankle foot orthosis

    kinematic (joint angle during gait cycle) and kinetic evaluation (power generation and absorption and moments) both with standard orthosis

    The evaluations are performed before the new ankle foot orthosis is delivered

  • gait analysis with experimental ankle foot orthosis

    kinematic (joint angle during gait cycle) and kinetic evaluation (power generation and absorption and moments) both with experimental orthosis

    The evaluations are performed 1 month after the new ankle foot orthosis is delivered

Secondary Outcomes (2)

  • G- sensor with standard ankle foot orthosis

    The evaluations are performed before the new ankle foot orthosis is delivered

  • G- sensor with experimental ankle foot orthosis

    The evaluation is performed 1 month after the new ankle foot orthosis is delivered

Study Arms (1)

orthosis in hemiplegia

EXPERIMENTAL
Device: experimental ankle foot orthosisDevice: traditional ankle foot orthosis

Interventions

On the basis of an accurate kinetic and kinematic analysis, a customized orthosis in thermoplastic material with carbon inserts will be created that will make the brace more elastic and facilitate the child's motor activities.

orthosis in hemiplegia

The normal afos in thermoplastic material, while guaranteeing an ankle joint stability, make the joint more rigid and reduce the elasticity of movement especially during running, jumping and sprinting.

orthosis in hemiplegia

Eligibility Criteria

Age6 Years - 11 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Users of Ankle Foot Orthosis (AFO) without any time limit;
  • GMFCS 1-2 scale values;
  • Ashworth triceps sural values \<= 3.

You may not qualify if:

  • patients using knee and hip orthoses (KAFO, HKAFO);
  • patients who need assisted walking (use of crutches, walkers or other);
  • uncooperative patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS E. Medea

Bosisio Parini, LC, 23842, Italy

Location

MeSH Terms

Conditions

Cerebral PalsyHemiplegia

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2021

First Posted

March 11, 2021

Study Start

September 1, 2020

Primary Completion

November 30, 2021

Study Completion

November 30, 2021

Last Updated

May 1, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations